CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
Tadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, Takashi Hagiwara, Takeshi Kawaberi, Haruhiko Ogata, Toshiyuki Matsui, Mamoru Watanabe, Toshifumi Hibi
Intest Res. 2021;19(4):408-418.   Published online November 20, 2020
DOI: https://doi.org/10.5217/ir.2020.00025

Excel Download

Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
Intestinal Research. 2021;19(4):408-418   Crossref logo
Link1 Link2 Link3

Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study
Intestinal Research. 2021;19(3):301-312   Crossref logo
Link1 Link2 Link3

Long-term safety and effectiveness of adalimumab for the treatment of Japanese patients with rheumatoid arthritis: 3-year results from a postmarketing surveillance of 552 patients
Modern Rheumatology. 2017;28(1):30-38   Crossref logo
Link1 Link2

Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM)
Expert Opinion on Pharmacotherapy. 2020;22(3):373-387   Crossref logo
Link1

Editorial: real-world short-term effectiveness of ustekinumab in 305 patients with Crohn’s disease-results from the ENEIDA registry
Alimentary Pharmacology & Therapeutics. 2019;50(5):599-600   Crossref logo
Link1 Link2

Editorial: real-world short-term effectiveness of ustekinumab in 305 patients with Crohn’s disease-results from the ENEIDA registry. Authors' reply
Alimentary Pharmacology & Therapeutics. 2019;50(5):600-601   Crossref logo
Link1 Link2

Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice
Digestive Diseases. 2018;37(1):11-20   Crossref logo
Link1 Link2

Real-world evidence for long-term safety and effectiveness of ipragliflozin in treatment-naïve versus non-naïve Japanese patients with type 2 diabetes mellitus: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM)
Diabetology International. 2021;12(4):430-444   Crossref logo
Link1 Link2 Link3

Real-world Short-term Effectiveness of Ustekinumab in Crohn’s Disease: Results from a Multicenter, Prospective Study in China
Inflammatory Bowel Diseases. 2022;28(Supplement_2):S42-S44   Crossref logo
Link1 Link2 Link3

P469 The PROPER study: interim analysis of a pan-European real-world study of SB5 adalimumab biosimilar after transition from reference adalimumab in patients with Crohn’s disease
Journal of Crohn's and Colitis. 2021;15(Supplement_1):S459-S460   Crossref logo
Link1 Link2